News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

April 26, 2023
April 26, 2023
Categories

An AI algorithm may help better guide oropharynx cancer treatment

Do you like it?
Read more
April 21, 2023
April 21, 2023
Categories

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

Do you like it?
Read more
April 19, 2023
April 19, 2023
Categories

The March/April 2023 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
April 7, 2023
April 7, 2023
Categories

American College of Radiology (ACR) leader highlights TMIST mammography trial in testimony supporting NIH funding increase

Do you like it?
Read more
April 6, 2023
April 6, 2023
Categories

E1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma

Do you like it?
Read more
March 23, 2023
March 23, 2023
Categories

The Spring 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
March 21, 2023
March 21, 2023
Categories

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

Do you like it?
Read more
March 8, 2023
March 8, 2023
Categories

The ComboMATCH patient registration trial and three treatment trials are now open

Do you like it?
Read more
February 27, 2023
February 27, 2023
Categories

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

Do you like it?
Read more
February 23, 2023
February 23, 2023
Categories

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

The January/February 2023 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

Do you like it?
Read more
February 9, 2023
February 9, 2023
Categories

The application period is now open for Spring Meeting Attendance Awards for minority trainees

Do you like it?
Read more
February 6, 2023
February 6, 2023
Categories

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

Do you like it?
Read more
February 1, 2023
February 1, 2023
Categories

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

Do you like it?
Read more
January 30, 2023
January 30, 2023
Categories

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

Do you like it?
Read more
January 24, 2023
January 24, 2023
Categories

Blinatumomab significantly improves overall survival in newly diagnosed B-ALL patients who are MRD-negative after initial treatment (study E1910)

Do you like it?
Read more
January 5, 2023
January 5, 2023
Categories

The Winter 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Breast cancer Cancer screening Cancer treatment Care delivery Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing Genomic testing GI cancer Group meeting Head and neck cancer Health equity Hogkin lymphoma Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Skin cancer Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group